Rybelsus is an oral semaglutide tablet that is already licensed in the UK, but it is licensed only for the treatment of type 2 diabetes and comes in doses up to 14mg
Annu Rev Pharmacol Toxicol 47:14383, PMID: 17029566 Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci N (2010) Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload
It raises GH and IGF-1 is a mechanism
These are programs that two makers of GLP-1s, Eli Lilly and Novo Nordisk, have established to allow patients to buy the medicines without using insurance at cash prices that are considerably lower than the list prices: As low as $149 for starter doses and between $250 and $375 for monthly maintenance doses